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Abstract
Taxus wallichiana Zucc. or the Himalayan Yew is a gymnosperm growing along the Himalayan
region  of  Indian  and  adjoining  countries.  The  plant  is  extensively  used  by  local  people  for
treatment of various diseases such as fever, headache, diarrhea, fractures, problems of nervous
system  etc.  It  also  finds  usage  in  Unani  system  of  medicine.    The  plant  is  rich  in  various
bioorganic  compounds  natural  products  such  as  hydrocarbons,  terpene  alcohols,  terpenoids
(including  taxoids),  organic  acids  etc.  The  plant  has  been  explored  for  anti-inflammatory,
analgesic,  antipyretic,  anticonvulsant,  immunomodulatory,  hepatoprotective  and  anticancer
activity with satisfactory outcome.  The pharmacological activity of the plant is largely due to the
presence of large number of   terpenoids. The bioactive constituents present in the plant interacts
with a large number of biochemical pathways involved in inflammatory processes, cell division
cycles  and inhibits  a number of  enzymes to bring about its  protective action against  various
diseases.  In  this review,  an attempt have been made to highlight  the beneficial  properties  of
Taxus wallichiana  in various levels of usage starting from its fundamental ethnobotanical use to
pharmacological  use  involving  both  in-vitro and  in-vivo  studies.  Insights  into  the  molecular
mechanisms of action of the active constituents in bringing about the beneficial activity have also
been illustrated. The plant can very well become a source of medicine for better management of a
large number of diseases including cancer.
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Introduction
The  Himalayan  region has  been  a  rich  source  of
medicinal  plants  for  millions  of  population
inhabiting  in  around  the  mountain  ranges.  The
Himalayan  region  is  rich  in  floral  diversity  and
plants are extensively used by local people for their
daily  needs  ranging  from  thatching  and  shelter,
fuel,  fodder,  house hold items,    medicines (1,  2).
The  Indian  Himalayan  region  presently  houses
8000 species of vascular plants of which 1748 are
known  to  possess  medicinal  properties  (3).
Himalayan mountains are home of 232 families of
angiosperms representing  2302 genera and 10452
species while the gymnosperms are represented by
8  families,  20  genera  and  51  species  (4).  Taxus
wallichiana is one such gymnosperm that grows in
the Himalayan region. It is a small to medium sized
evergreen tree with a height of 10 m to 28 m (5).
The  plant  is  widely  distributed  in  Asia  and  its
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occurrence spans from Afghanistan in the west to
Philippines  in  the east  and widely distributed in
Himalayan  regions  of  India  and  adjoining
countries (6).
T. wallichiana is traditionally used by local
people  of  Indian  subcontinent  for  the  cure  of  a
number of ailments.  In India,  tincture prepared
from aerial part of the plant is traditionally used
for  treatment  of  several  diseases  of  central
nervous  system  such  as  hysteria,  grittiness,
biliousness,  epilepsy  and nervousness.  The  plant
also forms one of the components of the popular
unani  drug  ‘Zarnab’  which  is  known  to  possess
sedative  and  aphrodisiac  properties  (7).  T.
wallichiana is also used indigenously by people of
Nepal for curing respiratory problems, bronchitis
and cancer (8).  The leaves of  T. wallichiana    is
also used to prepare herbal tea for cure of epilepsy
and indigestion (9).  T. wallichiana is also reported
to  have  immunomodulatory,  anti-bacterial,  anti-
fungal, analgesic, anti-pyretic and anti-convulsant
activities  (10).  Thus,  based  on  the  available
reports, an attempt has been made to review the
entire  domain  of  beneficial  properties  of  T.
wallichiana  with special emphasis on its chemical
constituents,  ethnobotanical  uses  and
pharmaceutical applications.
Methodology
Extensive literature survey have been done using
internet with PubMed, google scholar forming the
search  platform.  Relevant  research  papers  and
review  articles  were  selected  in  framing  the
article. The entire review article has been divided
into an introductory phase which briefly describes
geographical  distribution,  morphological  features
and taxonomic classification of Taxus wallichiana.
Introductory  segment  is  followed  by  detailed
account  of  ethnobotanical  uses of  the plant.  The
article then extends into further insights into the
chemical  constituents  of  the  plant  and
pharmacological  uses  and  culminates  with  the
discussion and conclusive remarks on the mode of
action  of  the  active  principles  in  bringing  about
the  pharmacological  activities.  The  chemical
structures  have  been  drawn  using  ACD/Chem
sketch Freeware 2018.2.5.
Results
Geographical distribution
Taxus  wallichiana grows  throughout  the
Himalayan region. In India it is widely distributed
in  the  temperate  zone  of  Himalayan  mountains
between altitudes of 1800m to 3300m above mean
seal  level  (11).  It  is  a  slow  growing  understory
species occurring  in  forests  of  Indian Himalayas
and  grows  with  Abies  pindrow,  Quercus
semecarpifolia,  Q. floribunda,  Q. leucotrichophora,
Betula  utilis,  Acer  caesium,  Pinus  wallichiana,
Rhododendron arboreum and  Betula alnoides  (12).
In  the  eastern  Himalayas,  the  species  grows  in
moist temperate zones at an altitude between 1600
to  2700  meters  in  West  Kameng,  Tawang,  Lohit
and Dibang Valley districts of Arunachal Pradesh
(13).  The  plant  also  grows  in  hilly  regions  of
Manipur  and  Meghalaya  in  north-eastern  India
(14). In Nepal, the plant is found in Rasuwa, Kavre,
Kaski,  Gorkha,  Dolakha,  Sindhupalanchok,
Lamjung,  Myagdi,  Sakhuwasabha,  Taplejung  and
Katmandu  districts  (15).  It   is  also  found in  the
Kanchenjunga  landscape,  a  region  of  eastern
Nepal  (parts  of  Taplejung,  Panchthar,  Ilam  and
Jhapa  districts),  Sikkim  and  North  Bengal
(Darjeeling  and  Jalpaiguri,  and  recently  formed
Alipurduar and Kalimpong districts) in India, and
western Bhutan (portions of Haa, Chukha, Samtse,
Dagana and Paro districts)  (16).   In Pakistan, the
plant is present in Murree hills, Hazara, Swat, Dir,
Chitral  as  undergrowth  of  other  conifers  and
broad  leaved  deciduous  plants  (17).  It  is  also
reported  from  Gilgit-baltistan  and  also  in  SWAT
valley  on  the  foot  hills  of  Hindukhush  range  in
Pakistan (18, 19).
Description of the plant
Taxus wallichiana  is a dioecious tree species (20).
The stems are fluted with spreading branches. The
barks are thin, reddish brown and scale like (21).
Leaves  dark  grey  in  colour,  glossy  green  above,
paler  beneath,  linear,  2-3.8  ×  0.3  cm  in  length,
coriaceous,  flattened,  arranged  in  two  vertical
opposite rows. Cones are axillary and sessile. Male
cones  are  solitary,  axillary,  sub-globose,  bracts
empty, with ten stamens. Female cones are solitary
with  few  imbricate  scales  surrounding  an  erect
ovule.  Ovules  are  surrounded  at  base  by
membranous  cup  shaped  disc.  Fruit  have  bright
red  disc  (Fig  1),  succulent,  enlarged,  7-8  mm  in
length.  Seeds  are  olive-green  in  colour.  Seeds
dispersed  by  birds  and  animals.  Growth  of  the
trees are extremely low with 12-14 annual  rings
per 2.5 cm radius and girth increment 0.4 to 1.3 cm
per year (22).  
Taxonomic  hierarchy  (IUCN  Taxonomic
hierarchy)
Kingdom: Plantae
    Division: Tracheophyta
        Class: Coniferopsida
Order: Coniferales
     Family: Taxaceae
           Genus: Taxus
  Species: wallichiana (23) 
Synonym: Taxus baccata L. ssp. Wallichiana Zucc.
Pilg.
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Fig 1. Picture of  Taxus wallichiana Zucc. showing ripe female
fructification (24)
Population and Conservation status 
Populations of  Taxus wallichiana were existent in
Himalayan regions since 3Ma BP (25). The plant is
traditionally and extensively used by the locals of
Himalayan region largely for primary healthcare
purpose (26, 27). This has resulted in unregulated
and unscientific harvesting of the plant ultimately
leading  to  the  decline  and  fragmentation  of
populations  (28).  The  plant  is  thus  marked  as
‘Endangered’  in  IUCN  redlist  with  a  continuous
decrease  in  population  (29).  The  plant  is  also
included in CITES and negative list  of  exports  of
the government of India (30).
Ethnobotanical uses
Taxus  wallichiana has  been  a  plant  of  immense
ethnobotanical  use  amongst  the  local  people
dwelling in the Himalayan region. They largely use
T. wallichiana to cure various diseases. The various
ethnobotanical use of  T. wallichiana across various
regions of Himalaya has been compiled in Table 1.
Table.1 Ethnobotanical  use of  Taxus wallichiana Zucc.  across
various Himalayan regions
# Region Vernacular Name Ethnobotanical uses Ref.
1. Asi Ganga sub 
basin, 
Uttarakhand, 
India
Thuner
Bark and seed extract with warm
water is given orally for 
treatment of internal wound.  (31)
2. Urgam valley, 
Chamoli 
Garhwal, 
Uttarakhand, 
India
Thuner
Bark extract is used as tea for 
treatment of high blood 
pressure.  (32)
3. Nanda Devi 
Biosphere 
Reserve, 
Uttarakhand, 
India
Thuner
Bark used as a substitute of tea. 
The powdered bark is used for 
the treatment of cold.  (33)
4. Kedarnath 
wildlife 
sanctuary, 
Garhwal 
Himalayas, 
Uttarakhand, 
India
Bark and bark paste used for the 
treatment of fractured bones, 
headache, breast piles
 (34)
5. Niti Valley, 
Uttarakhand, 
India
Thuner
Dry powder of bark with salt and
ghee is mixed with water to 
make tea and used for treatment 
of high blood pressure and 
cancer.
Paste of bark with egg yolk is 
used as plaster for treatment of 
fracture.
 (35)
6. Jakholi Block, Thuner Juice of leaves are used for the  (36)
Rudraprayag 
district, 
Uttarakhand, 
India
treatment of boils, cuts and 
wounds
7. Mornaula 
Reserve forest, 
Kumaon, 
Uttarakhand, 
India
Thuner
Bark, oil and leaves are used for 
treatment of cancer. Bark is also 
used as fuel.  (37)
8. Shimla Hills, 
Himachal 
Pradesh, India
Thuno, 
Barmi
Tincture from young shoots are 
used for treatment of headache, 
giddiness, feeble and falling 
pulse, diarrhoea and severe 
biliousness. Leaves are 
antispasmodic and used for 
treatment of nervousness, 
hysteria, epilepsy and stones.
 (38)
9. Manali wildlife 
sanctuary, 
Himachal 
Pradesh
Rakhal
Barks and leaves are used for 
treatment of cancer, swelling 
and as contraceptive.  (39)
10. Pabbar Valley, 
Himachal 
Pradesh
Thuna Tea prepared from needle and 
bark are used for treatment of 
congestion and cough.
 (40)
11. Mandi and 
Hamirpur 
district, 
Himachal 
Pradesh
Rakhala/ 
Talispatra
Tea prepared from barks and 
leaves are used to treat asthma. 
Bark is used for the treatment of 
cancer.
 (41)
12. Churah 
subdivision, 
District 
Chamba, 
Himachal 
Pradesh, India
Nadgaun/
Brahmi
Bark is used as flavouring agent.
 (42)
13. Shimla water 
catchment 
sanctuary, 
Himachal 
Pradesh, India
Rakhal
Leaves used to cure cancer. Bark 
used for preparation of tea.
 (43)
14. Kathua, Jammu
& Kashmir, 
India
Barmi Decoction of leaves are used to 
cure asthma, bronchitis, cough, 
indigestion and epilepsy.
 (44,
45)
15. Rajouri, 
Jammu & 
Kashmir, India
Barmi Decoction of leaves are used to 
cure asthma, bronchitis and 
cough.
 (46)
16. Ganderbal, 
Kashmir, India
Tea prepared from boiling bark 
in water is used for cure of 
asthma, giddiness, arthritis, 
tumour growths.
 (47)
17. Bangus valley, 
Kashmir, India Postul
Tea made from bark is used to 
cure sickness in winter.  (48)
18. Bandipora, 
Jammu and 
Kashmir, India
Postul
/Brammi
Bark extract is made into a tea 
and is used for curing of asthma, 
headache, giddiness, tumour 
growths.
 (49)
19. Galliyat, NWFP,
Pakistan Bermi
Decoction of stem is used for 
treatment of tuberculosis.  (50)
20. Neelam valley, 
Muzaffarabad, 
Pakistan 
occupied 
Kashmir
Birmi
Tea from leaves are used to cure 
asthma and high fever.
 (51)
21. Leepa valley, 
Muzaffarabad, 
Pakistan 
occupied 
Kashmir
Birmi
Leaf and bark extract is used to 
treat tumours. Decoction of leaf 
with honey is used for the 
treatment of hey fever, 
flatulation, epilepsy and asthma.
 (52)
22. Kel, Pakistan 
occupied 
Kashmir
Decoction of bark is used for 
treatment of cancer.
(53)
23. Shogran valley,
Pakistan
Plant used for the treatment of 
cancer, cardiac disorders, head 
ache, renal disorders and 
digestive disorders. The plant is 
antispasmodic, purgative and 
antirheumatic.
 (54)
24. Manaslu, 
Sagarmatha 
and 
Kanchenjunga  
region, Nepal
Used for treatment of cancer and
jaundice.
 (55)
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Chemical constituents
Taxus  wallichiana has  been  a  plant  of  extensive
study due to its diverse ethnobotanical uses.  The
plant  also  exhibits  a  wide  range  of
pharmacological  properties  and  detailed
investigations about  the chemical  constituents  of
the plant have been undertaken by a number of
researchers. Essential oil is a major ingredient of
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Table  2. Major constituents of different plant parts of Taxus wallichiana Zucc
Plant Parts Nature of Compounds Name of Compound Ref.
Essential 
oil from 
leaves
Alkane n-Eicosane; Docosane ; n-Pentacosane.
(67)
Alkene Santolinatriene.
Alcohol
Geraniol; Globulol; Eugenol; Myrtenol; (E)-Verbenol; n-Hexenol; (Z)-3-Hexenol; (E)-2-
Hexenol; n-Hep-tan-2-ol; 1-Hepten-3-ol; (E)-2-Octen-1-ol; (Z)-2-Octen-1-ol; (E)-2-Nonenol; 
1-Octanol.
Aldehyde Benzaldehyde; Anisaldehyde; n-Heptanal; n-Octanal; (E)-2-Octenal; n-Nonanal; (E)-2-Nonenal; Dodecanal.
Organic acids Benzoic acid; Hexanoic acid.
Organic acid esters
( Z)-3-Hexenyl formate; Octyl formate; (Z)-3-Hexenyl acetate; (E)-2-Hexenyl acetate; (E)-3-
Heptenyl acetate; Benzyl acetate; Anisyl acetate;n-Octyl acetate; Sabinyl acetate;(E)-2-
Hexenyl-n-hexanoate;Isopropyl-n-octanoate;  (Z)-3-Hexenyl benzoate; Methyl benzoate; 
Geranyl-n-heptanoate; Geranyl benzoate;n-Amyl anisoate; Geranyl tiglate; Methyl 
salicylate.
Terpenes
α-Pinene; β-Pinene; Camphor; β-Caryophyllene; Caryophyllene oxide; (Z)-β-Ocimene; (Z)-
Sabinene hydrate; (Z)-Pinene hydrate.
Leaves
 Taxoids 
(terpenoids)
Taxol; 10-deacetylbaccatin III; baccatin IV; 1-hydroxybaccatin I; 2’-
deacetoxydecinnamoyltaxinine J; 2’-deacetoxytaxinine J;2-acetoxybrevifoliol  (68)
Brevifoliol;2-acetoxybrevifoliol  (68, 69)
5αO-(3′-dimethylamino-3′-phenylpropionyl) taxinine M;7-O-acetyltaxine A; 2α-acetoxy-
2′β-deacetylaustrospicatine.  (70)
14-β-hydroxy- 10- deacetylbaccatin III;2-Debenzoyl-14β-benzoyloxy-10-deacetylbaccatin 
III; 14β-Hydroxy-1 0-deacetylbaccatin V.  (71)
19-debenzoyl-19-acetyltaxinineM; 13-deacetyltaxuspine A; 10-debenzoy1-2a-
acetoxybrevifoliol,  (72)
2-deacetoxytaxinine B  (73)
Wallifoliol; cephalomannine; 1-O-deacetylbaccatin 11  (69)
Barks Ketone 4-(4’-hydroxyphenyl)-2-butanone
 (56)
Alcohol 4-(4’-hydroxyphenyl)-2-butanol; 9-hydroxy-4,7-megastigmadiene-3-one-3-oxo-α-ionol
Taxoids 
(Terpenoids)
Taxayuntin E ; Taxayuntin G; Taxayuntin J;  Taxinine A;2-Deacetoxy taxinine B; 2-
Deacetyl-5-decinnamoyl taxinine E;Taxinine J ; 2-Deacetoxy taxinine J ;5-Decinnamoyl 
taxinine J;   Taxinine M; 19-Debenzoyl-19-acetyl taxinine M; Taxchin A;Taxchin B; 1-
Hydroxy-5-deacetyl baccatin I; Baccatin III; Baccatin IV; 10,13-Deacetyl-abeobaccatin IV; 
1-Dehydroxy baccatin VI;13-Deacetyl baccatin VI;9-O-Benzoyl-9,10-dideacetyl (15-1)-abeo 
baccatin VI;9-Benzoyl-9-deacetyl11(15-1)abeo baccatin VI  Taxayunnanine C; 2’-Deacetyl 
austrotaxine, 2-Acetoxy-2’,7-dideacetoxy-1-hydroxy austrospicatine; 2-Acetoxy-2’-
deacetoxy austrospicatine; 2’-Deacetoxy austrospicatine; 7-Xylosyl-10-deacetyl taxol D; 7-
Xylosyl-10-deacetyl taxol;10-Deacetyl taxol; 7-Xylosyl taxol; 7-Xylosyl-10-deacetyl taxol C; 
N-Methyl taxol C ;10-Deacetyl epi-taxol; 7-Xylosyl taxol C; Epi-taxol; 2-Benzoyloxy-7,9,10, 
13-tetraacetoxy-4(20); 11 –taxadiene,2,5,9-Trihydroxy-10, 13-diacetoxy-4(20), 11-
taxadiene; 5-Hydroxy-9,10-dia-cetoxy-13-oxo-4(20), 11-taxadiene; 2-Hydroxy-5,10,14-
triacetoxy 4(20), 11-taxadiene; 5,7,9,10,13-Pentaacetoxy 4(20), 11-taxadiene;7,9,10,13-
Tetraacetoxy-5-(3’-acetylamino3’-phenyl)propionyloxy-4(20), 11-taxadiene;Hydroxy-
triacetoxy-5(3’-dimethylamino-3’phenyl)propionyloxy4(20), 11-
taxadiene;Taxusin;Yunnanxane.
 (74)
Heart wood
Taxoids
Taxusin ; 7-xylosyl-10deacetyltaxol C.  (75)
13-acetyl-13-decinnamoyltaxchinin.  (76)
Roots Taxoids Baccatin III; Baccatin IV; Taxusin; 1β-hydroxybaccatin I; Penta acetoxy taxadiene 7; 7-xyloxyl-10-deacetyl-taxol.  (65)
Lignans (-) Seco-isolariciresinol; Taxiresinol; Isotaxiresinol.
Lignans
α-Conidendrin; Formosanol; Methyl-α-Conidendral; α-Intermedianol;1, 4-methano-2-
benzoxepin-10-methanol, 1, 3, 4, 5-tetrahydro-7-hydroxy-5-(4-hydroxy-3methoxyphenyl)-
8-methoxy.  (66)
Sesquiterpene 
lactone
Cinnamolide.
Seeds Triterpenoid Ursolic acid.
 (77)Cyanogenic glucoside
Amygdalin.
Phytosterol β-Sitosterol.
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leaves obtained through hydrodystillation process.
The  major  constituents  of  essential  oil  are  long
chain  hydrocarbons,  terpene  alcohols  such  as
geraniol,  globulol,  eugenol,  myrtenol  and  (E)-
verbenol.  In  addition  to  it,  the  essential  oil  also
contains  fatty  alcohol  such  with  varying  chain
length, aldehydes, organic acid esters and terpenes
(56).  These  terpenes  and  terpene  alcohols  are
largely responsible for the characteristic fragrance
of essential oil (57). In addition to essential oils, all
parts  of  T.  wallichiana contains the most  unique
group  of  compound  by  the  name  taxoids  or
taxanes. These compounds are largely responsible
for  pharmacological  activities  of  Taxus  (58,  59).
The  taxoids  are  fundamentally  diterpenoids  and
contains 6/8/6-membered ring skeleton known as
taxane skeleton which is chemically a pentamethyl
[9.3.1.0] 3, 8 tricyclopentadecane skeleton (60, 61).
The most important and pharmacologically
important representative of the taxoids present in
T.  wallichiana is  Taxol.  The  biogenesis  of  taxol
involves  the  condensation  of  the  three  isoprenyl
diphosphate  (IPP)  units  with  dimethylallyl
diphosphate (DMAPP) both of which are produced
either  through  mevalonic  (MVA)  pathway  in  the
cytosol  or  via  the  methyl  erythritol  phosphate
(MEP)  pathway  in  plastids.  The  first  determining
step  in  the  biogenetic  pathway  is  cyclization  of
geranyl  geranyl  diphosphate  (GGPP)  to  taxadiene
followed  by  eight  cytochrome  P450-mediated
oxygenations,  three  CoA-dependent  acyl/aroyl
transfers, an oxidation at C9, and oxetane (D-ring)
formation  finally  resulting  in  formation  of
intermediate baccatin III (62, 63)  (Fig. 2).  The final
stage of taxol biosynthesis involves the assembly of
C13 side chain appended to the Baccatin molecule
(64).  Analysis of bark,  root and other parts of the
plants revealed the presence of taxol, baccatins and
other intermediary molecules and taxol analogues
(Table  2).  Apart  from taxoids,  T.  wallichiana also
contains  lignans  such  as  (-)  seco-isolariciresinol,
taxiresinol,  isotaxiresinol,  formasonol,
sesqueterpene  lactone,  triterpenoid  cyanogenic
glucoside  and  phytosterols  (65,  66).  Chemical
structures  of  selected  compounds  present  in  T.
wallichiana is depicted in Figs. 2, 3 & 4 respectively.
Most  of  these  compounds  have  been reported  to
have  pharmacological  importance  and have  been
discussed  in  this  article.  The  various  compounds
isolated from different parts of  T. wallichiana are
listed in Table 2.
Pharmacological  activities  of  Taxus
wallichiana Zucc.
Anti-inflammatory activity
Inflammation is associated with onset of a number
of  diseases  including  asthma  (78),  rheumatoid
arthritis (79), atherosclerosis (80), chronic venous
insufficiency  (81),  diabetes  (82),  cancer  (83)  etc.
Herbal  remedies  have  proven  to  be  an  effective
way to reduce inflammatory processes (84). In the
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Fig 3. Chemical structures of selected Taxoids present in 
Taxus wallichiana Zucc.
Fig 4. Chemical Structure of selected alcohols present in 
Taxus wallichiana Zucc.
Plant Science Today (2020) 7(1): 122-134
same  line  Taxus  wallichiana have  proven  its
efficacy  to  combat  inflammatory  processes.
Taxusabietane A, isolated from T. wallichiana was
reported to possess anti-inflammatory potential. 
Fig  2. Schematic representation of major steps associated with 
biosynthesis of taxol
IPP: isopentenyldiphosphate
DMAPP: dimethylallyldiphosphate
GGDP: Geranylgeranyldiphosphate
IPPI: isopentenyldiphosphateisomerase
GGPPS: geranylgeranyldiphosphate synthase
TS: taxadiene synthase
The results obtained from a study indicated
that  taxusabietane  A  showed  lipoxygenase
inhibitory activity  with an IC50 value of 57±0.31
µM which was significant in relation to standard
compounds baicalein and tenidap sodium with an
IC50 value  of  22.1±0.03  and  41.6±0.02µM
respectively. In addition to it,  taxusabietane A at
5mg/kg  and  10mg/kg  dose  also  inhibited
carrageenan induced oedema in adult wistar rats
though  in  this  case  standard  compound
indomethacin  at  same  dose  exhibited
comparatively  better result  (85).    Another study
reported that taxoids namely tasumatrol B, 1, 13-
diacetyl-10-deacetyl  baccatin  III  (10-DAD)  and  4-
deacetylbaccatin  III  (4-DAB),  isolated  from  T.
wallichiana  is  significantly  effective  in  bringing
down inflammations induced by carrageenan and
cotton pellet in  rats.  At  20mg/kg and 40mg/kg of
dose,  the  tested  compounds  showed  significant
inhibition of paw oedema in carrageenan induced
inflammation  model  out  of  which  tasumatrol  B
was observed to be most effective. In addition to it,
cotton  pellet  test  revealed  that  all  the  three  test
compounds  showed  inhibition  against
inflammation  and  granuloma  accumulation  (86).
Two  more  abietane  diterpenoids  namely
taxusabietane  C  and  taxamairin  F  have  also
reported  to  show  lipoxygenase  inhibitory  effect
with 69 ± 0.31 and 73 ± 0.14 µM, respectively (87).
Analgesic,  antipyretic  and  anticonvulsant
activity
The  analgesic  activity  of  tasumatrol  B,  a  taxane
isolated from the bark of  Taxus wallichiana have
been  reported,  It  has  been  observed  that
tasumatrol  B  administered  at  40mg/kg  in  wistar
rats significantly decreased the writhing count in
acetic acid writhing experiment (86). The analgesic
activity  of  T.  wallichiana was  observed  by  the
formalin  test  in  rats.  It  was  observed  that  upon
treatment  with  50,  100  and  200  mg/kg  of  the
extract of T. wallichiana to rats previously injected
with 0.05 ml of formalin in the plantar surface of
hind  paw,  the  pain  score  severity  showed  a
concentration dependent decline in both early and
late  phases  of  analgesia.  In  addition  to  it,  the
antipyretic  activity  was  investigated  by  injecting
15% aqueous solution of yeast at 10 ml/kg dose to
induce  pyrexia.  This  was  followed  by
intraperitoneal injection of 50, 100 and 200 mg/kg
of extract. It was observed that all the dose of plant
extract  showed  significant  inhibition  of  pyrexia
induced by yeast and the antipyretic effect of 200
mg/kg  of  extract  is  comparable  to  20  mg/kg  of
paracetamol  between  30  and  60  minute  of
treatment.  The  anticonvulsant  activity  was  also
tested  observing  the  effect  of  plant  extracts  on
pentylenetetrazole induced seizers in rats. It was
observed that pretreatment of 50, 100 and 200 mg/
kg  of  plant  extract  significantly  reduced
mioclonous seizures. Additionally, 100 and 200 mg/
kg  of  extracts  significantly  delayed  the  onset  of
first  clonous seizures while 200 mg/kg of extract
delayed the tonous seizures. Extracts of all doses
protected  the  rats  from  tonic-clonic  seizures.
Diazepam  was  used  as  a  control  and  showed
remarkable  anticonvulsant  activity  at  7.5  mg/kg.
There  was  also  a  decrease  in  percentage  of
mortality  in  animals  upon  pretreatment  with
extracts (88).
Hepatoprotective activity
The  protective  action  of  methanolic  extract  of
Taxus  wallichiana against  carbon  tetrachloride
induced hepatotoxicity in rats was reported from a
recent study. It was observed that CCl4 treatment
resulted  in  significant  elevation  of  liver  enzyme
markers  namely  aspartate  transaminase  (AST),
alanine  transaminase  (ALT)  and  lactate
dehydrogenase (LDH). Treatment of animals with
1 ml of 100 and 300 mg/kg/body weight resulted in
decrease  in  the  levels  of  liver  marker  enzymes
histopathological  investigation  of  liver  of  rats
treated  with  plant  extracts   revealed  an  almost
normal hepatic  architecture  with less infiltration
of fat and absence of necrosis all of  which were
prominent  in  rats  treated  with  carbon
tetrachloride (89).
Immunomodulatory activity
The  immunomodulatory  potential  of  Taxus
wallichiana was  investigated  using  human
lymphocyte  as  the  experimental  system.  In  the
experiment,  cyclophosphamide  was  used  to
supress the proliferation of lymphocytes and this
condition  was  reversed  by  cotreatment  of  1-
hydroxy-2-deacetoxy-5-decinnamoyl-taxinine  J  (1
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µg/ml) with concanavaline A (5 µg/ml), an immune
stimulant (90).
Anticancer activity
Some studies have been undertaken to investigate
the  anticancer  potential  of  compounds  isolated
from  Taxus wallichiana.  A  study  reported that  1-
hydroxy-2-deacetoxy-5-decinnamoyl-taxinine J was
cytotoxic  to  five  cancer  cell  lines  namely  MCF7,
WRL-68, KB, PA-1, Colo 320DM human cancer cell
lines as determined by MTT and clonogenic assays
(90).  Another  study  have  shown  cytotoxicity of
taxiresinol, a lignan isolated from heartwood of the
plant  against  human  liver,  colon,  ovarian  and
breast  cancer cell  lines (91).  Taxawallin  I,  a  new
taxoid  isolated  from  T.  wallichiana has  been
reported to show toxicity against HepG2, A498, NCl-
H226 and MDR 2780AD cancer cells (92).  Another
study  reported  isolation  of  four  novel  taxane
derivatives  namely  N-debenzoyl-N-methyl-N-
heptanoyl-taxol, N-debenzoyl-N-me-thyl-N-octanoyl-
taxol,  N-debenzoyl-N-methyl-N-(4-methylhexanoyl)-
taxol,  and  N-debenzoyl-N-methyl-N-[(4Z)-1-oxo-4-
tenenoyl]-taxol from ethanol extract of whole plant.
It is also reported that the taxanes were inhibitory
towards  MCF-7,  A549,  and  3-AO cancer  cell  lines
and had microtubule stabilizing properties (93).
The term taxane or taxoids refers to all the
terpenoid compounds  having  molecular  structure
based  on baccatin  unit,  either  obtained naturally
from  Taxus  sp or  are  semi  synthetically  or
synthetically  prepared  exhibiting  anticancer
properties. Taxanes interacts with the microtubules
involved in  mitotic  process.  Taxanes stabilize  the
microtubules  of  cells  which  counteract  their
depolimerization.  Thus,  correct  separation  of  two
identical sets of chromosomes and their consequent
transfer during cell division are inhibited resulting
in blockage of cell mitosis ultimately leading to cell
death  (94).  Taxanes  promote  microtubule
polymerization  and  arrest  mitosis  through
activation  of  spindle  assembly  check  point  and
keeping a small number of unattached kinetochores
to the microtubules.  This delays mitotic metaphase
progression  and  inhibits  anaphase  prompting
complex  (95).  On  a  molecular  level,  binds  to  a
pocket in β- tubulin that faces microtubule lumen
and  is  near  the  lateral  interface  between
protofilaments  thereby  affecting  normal  function
and  cellular  processes  (96).  The  binding  of
Paclitaxel  to  β-  tubulin  subunit  results  in
stabilization of microtubules through induction of
conformational changes of the M-loop of β- tubulin
which  result  in  more  stable  lateral  interaction
between adjacent protofilaments thereby changing
microtubule  dynamics and inducing mitotic  block
and triggering apoptosis of cancer cells  (97, 98).
Moreover,  taxanes  also  exhibit  apoptotic
action  interacting  with  various  proteins  and
enzymes which are involved in cell cycle, apoptosis
and cell  death.  Increased reactive oxygen species
(ROS) is one of the earliest events of apoptosis and
is  brought  about  by  taxanes  (99).  Taxanes  also
initiate  decrease  in  mitochondrial  membrane
potential  (ΔΨm)  and  induces  opening  of
mitochondrial  membrane  permeability  pore
resulting  in  release of  calcium and cytochrome c
from  mitochondria  (100,  101).  Caspases  are  the
family of endoproteases that play an important role
in cell inflammation and cell death (102). Taxanes
also activates caspases thus initiating cell death and
apoptosis (103). B-cell lymphoma (Bcl-2) is the key
protein which regulates programmed cell death and
apoptosis  (104).  They  may  be  divided  into  two
major  groups  namely  (a)  antiapoptotic  protein
(BCL-2, BCL-XL, MCL-1, BFL-1, BCL-W, and BCL2L10)
and (b) proapoptotic proteins (BAK, BAX) (105). The
apoptosis  in  cancer  cells  is  further  induced  by
phosphorylation  and inactivation  of  antiapoptotic
Bcl-2  by  taxane  (106).  Along  with  Bcl-2,  p53  also
plays  a  major  role  in  apoptotic  process.  It  is  an
important tumour suppressor gene which regulates
downstream expression of other genes involved in
DNA repair,  cell  cycle  arrest  and apoptosis  (107).
Taxanes  are  reported  to  act  as  a  p53  inducers
thereby enhancing the apoptotic process (108). The
p21 is an universal cyclin dependent kinase (CDK)
inhibitor, controlled by p53 and physically interacts
and  inhibits  cyclin-CDK2,  cyclin-CDK1,  cyclin-
CDK4/6 complexes thus regulates progression of cell
cycle during G1 and S phases (109). Taxanes results
in increase of expression p21 through upregulation
of p53 (110).
Toxicity
Toxicity of Taxus sp is known to humans since early
civilization. Juice of the plant was applied to arrows
for hunting and leaves were used for homicide and
suicide (111).  The main active compounds of the
plant  include  a  mixture  of  diterpenoid  alkaloids
namely taxine A and B, isotaxine B, taxol B and are
responsible for toxicity causing  toxicity resulting in
the occurrence of symptoms like nausea, vomiting,
diffuse abdominal pain, tachycardia (initially) and
convulsions,  followed  by  bradycardia  and
respiratory muscle paralysis  (112). The time from
ingesting lethal dose of Taxus toxin to death usually
varies between 2-5 hours with symptoms occurring
between 30 minutes to 1 hour after ingestion (113).
Generally, the Taxus toxins acts by generation of a
block in  the distal portion of the conduction system
of the heart resulting in fatal arrhythmia (114). It is
further reported from a study that taxine-B inhibits
calcium and sodium transport in myocardial cells
and  interferes  with  heart’s  conducting  system
thereby acting as a cardiac depressant (115).
Conservational  approaches  and  production  of
bioactive compounds
The population of  Taxus wallichiana have taken a
toll due to its ever increasing demand among the
localites  accompanied  by  high rate  of  collection.
To  make  the  things  even  more  grave,  the  plant
exhibits slow growth and poor regeneration (116).
This  has  resulted  in  number  of  conservational
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approaches to save the population from extinction.
Tissue  culture  method  have  been  a  versatile
approach  for  mass  propagation  of  a  number  of
plants  (117).   The  long  dormancy  period  of  the
plant can overcome by culture of zygotic embryos
which can develop into full grown seedlings in 10-
12  weeks  (118).  A  study  reported  that  shoot
elongation  and  root  induction  through  shoot  tip
culture  is  feasible  and  may  be  applicable  for
propagation  of  the  plant  (119).  Another  study
reported regeneration of  T. wallichiana plant  via
shoot organogenesis from callus cultures derived
from  zygotic  embryos  (120).  Apart  from  tissue
culture  techniques,  stem  cuttings  treated  with
growth  promoting  substances  have  also  been
proved effective for propagation of the plant (121).
Another  recent  study  reported  that  treatment  of
shoot cuttings of the plant with indole acetic acid
(IAA),  indole  butyric  acid  (IBA)  and  napthoxy
acetic acid (NAA) resulted in effective initiation of
roots (122). Tissue culture techniques are not only
used  for  mass  propagation  but  also  for  the
production  of  bioactive  compounds.  There  have
been reports that extracts from the cell cultures of
the plant contains taxol, deacetyl baccatin III and
baccatin  III  (123).  Another  study  detected  the
presence of  taxol  (0.8499%)  in the callus  culture
(124).  Use  of  bioreactors  for  production  of  taxol
and  baccatin  III  from  suspension  cultures  have
also been reported from a study (125).
Discussion
The  genus  Taxus or  Yew  holds  immense
importance  globally  from  pharmacological  point
of  view.   A  lot  of  research  work  have  been
undertaken  to  explore  the  pharmacological
importance  of  the  genus.  The  most  important
amongst  them  is  exploration  of  Pacific  Yew  or
Taxus brevifolia . Exploration on the antineoplastic
activity  of  the  active  constituent  of  T.  brevifolia
started  way  back  in  1960  (126).  It  consequently
underwent  a  series  of  modifications  and
culminated in commercial production as Paclitaxel
by  Bristol-Myers  Squibb  (BMS)  in  the  year  1992
(127). Since then there have been no stopping and
a number of variants and semisynthetic analogues
such as docetaxel and cabazitaxel were developed
all  of  which  possess  same  anticancer  activity.
Moreover,  studies  showed  that  extracts  of
European  yew,  Taxus  baccata,  also  have  the
potential  to  inhibit  Caov-4  and HeLa  cancer  cell
lines (128). It is also reported from a study that the
bark  extract  of  T.  baccata also  possess  anti
inflammatory  properties  (129).  There  are  also
reports  that  the  leaves  of  T.  baccata also  have
bronchodilating properties and beneficial effect on
asthma  (130).  Japanese  Yew,  Taxus  cuspidata is
also reported to possess inhibitory activity against
MCF-7  (breast),  PG  and  A549  (lung),  PC-3M-1E8
(prostate),  BGC-823 (gastric),  WM451 (melanoma),
Bel-7402  (hepatocellular),  KB  (oral  squamous),
HeLa  (cervical),  and  HL-60  (leukemic)  cell  lines
(131).
Across the world there has been a growing
demand of herbal medicines and 80% of the total
population  are  relying  on  herbal  remedies  for
primary healthcare (132). The figures are similar
for  Indian  population  of  which  70%  relies  on
plants as source of medicines (133). Now coming
back to Himalayan Yew or Taxus wallichiana, it is
reported that the plant finds extensive use by the
people living in various location of Himalayas. The
use of plant has been assimilated in their tradition
and  thus  justifies  its  ethnobotanical  and
ethnomedicinal  significance.   Thus,  there  is  a
strong requirement for a reverse pharmacological
process  in  which  the  traditional  knowledge  and
usage  pattern  of  Himalayan  Yew  can  be  better
explored in the laboratory condition for validation
of its pharmacological efficacy. In this regard, the
plant has been investigated to some extent for a
number  of  pharmacological  activities  which  has
yielded promising outcome. Thus, this species is at
par with the other species of Taxus, many of which
have  been  extensively  investigated  for  their
pharmacological  actions.  However  most  of  the
investigations have been made of cell lines or in
animal  systems.  Experimentation  using  clinical
trials  using  humans  are  further  required  for
consequent  development  of  drugs.  Additionally,
exploration of anticancer potential from Taxus sp
has become a matter of priority since last 50 years
and  as  mentioned  earlier.  Paclitaxel  is  a  noble
outcome of extensive research on T. brevifolia. In a
similar  manner,  the Himalayan Yew can also  be
explored  further  for  its  anticancer  potential
leading to development and commercialization of
drugs required for cancer treatment. In this aspect
there are few reports of detection taxol in cell and
callus culture of  T. wallichiana.  This avenue also
needs further elaboration and investigation with a
motive of increasing the concentration and yield of
Taxol  through  modification  of  ambient  culture
condition.  This  would  lead  to  a  cost  effective
approach in the development of anticancer drugs
from T. wallichiana.  
Presently,  over  exploitation  of  T.
wallichiana have resulted in its depletion. Isolation
of population through habitat fragmentation leads
to  restriction  of  connectivity,  resulting  in  low
levels  of  gene flow between the  population with
subsequent  lower  genetic  diversity  and  higher
genetic  differentiation  in  and  among  remaining
populations  (134).  Moreover,  smaller  isolated
populations  also  undergo  frequent  inbreeding
which often express deleterious alleles leading to
reduction  in  reproductive  capacity  and  low
offspring  survival  (135).  Thus,  studies  on  the
genetic diversity of the plant is extremely relevant
as an important avenue towards conservation as
well  an  indicator  of  possible  extinction.  An
important  approach  towards  conservation  of
diminishing  population  of  T.  wallichiana is  to
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maintain an effective population size so that  the
level of genetic variation can be maintained. Thus,
proper planning and management of this species
in their natural habitat will be extremely fruitful
in harvesting pharmacologically active principles
from the  plant.  Techniques  of  molecular  biology
and biotechnology should also be involved in the
overall process of conservation.    
Conclusion
Taxus  wallichiana or  Himalayan  Yew  is  an
endangered  gymnosperm  that  grows  in  the
Himalayan  region  and  is  of  immense
Ethnobotanical  importance  amongst  the  people.
They  contain  huge  amount  of  phenolics  and
terpenoids  which  forms  the  backbone  of  their
medicinal  potential.  The  plant  has  proven  its
efficacy from pharmacological  point of view and
can be very well utilised as a cost effective source
of  medicine  for  management  of  diseases  of  the
people of Indian subcontinent. The bioprospection
of this plant thus becomes extremely relevant for
the benefit of humans.
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